FDA Approved: NASCOBAL — Supplemental Application (ENDO USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for NASCOBAL (cyanocobalamin) submitted by ENDO USA, Inc. This action updates the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cobalamin Deficiency
• Pernicious Anemia
• Vitamin B12 Deficiency

Drugs mentioned

• NASCOBAL (cyanocobalamin)

Snippet

SUPPL AP for NASCOBAL (CYANOCOBALAMIN)